2,256
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT

, , , , , , , , & show all
Pages 1591-1596 | Received 01 May 2017, Accepted 20 Jun 2017, Published online: 25 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jens Overgaard, Ludvig Paul Muren, Morten Høyer & Cai Grau. (2019) BIGART 2019 – adapting to the future. Acta Oncologica 58:10, pages 1323-1327.
Read now

Articles from other publishers (14)

Evelien A. J. van Genugten, Jetty A. M. Weijers, Sandra Heskamp, Manfred Kneilling, Michel M. van den Heuvel, Berber Piet, Johan Bussink, Lizza E. L. Hendriks & Erik H. J. G. Aarntzen. (2022) Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy. Frontiers in Oncology 11.
Crossref
Julien Ancel, Jeanne-Marie Perotin, Maxime Dewolf, Claire Launois, Pauline Mulette, Béatrice Nawrocki-Raby, Véronique Dalstein, Christine Gilles, Gaëtan Deslée, Myriam Polette & Valérian Dormoy. (2021) Hypoxia in Lung Cancer Management: A Translational Approach. Cancers 13:14, pages 3421.
Crossref
Andrew Hope, Maikel Verduin, Thomas J Dilling, Ananya Choudhury, Rianne Fijten, Leonard Wee, Hugo JWL Aerts, Issam El Naqa, Ross Mitchell, Marc Vooijs, Andre Dekker, Dirk de Ruysscher & Alberto Traverso. (2021) Artificial Intelligence Applications to Improve the Treatment of Locally Advanced Non-Small Cell Lung Cancers. Cancers 13:10, pages 2382.
Crossref
Iwona Ziółkowska-Suchanek. (2021) Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models. Cells 10:1, pages 141.
Crossref
Sebastian Sanduleanu, Arthur Jochems, Taman Upadhaya, Aniek J.G. Even, Ralph T.H. Leijenaar, Frank J.W.M. Dankers, Remy Klaassen, Henry C. Woodruff, Mathieu Hatt, Hans J.A.M. Kaanders, Olga Hamming-Vrieze, Hanneke W.M. van Laarhoven, Rathan M. Subramiam, Shao Hui Huang, Brian O'Sullivan, Scott V. Bratman, Ludwig J. Dubois, Razvan L. Miclea, Dario Di Perri, Xavier Geets, Mireia Crispin-Ortuzar, Aditya Apte, Joseph O. Deasy, Jung Hun Oh, Nancy Y. Lee, John L. Humm, Heiko Schöder, Dirk De Ruysscher, Frank Hoebers & Philippe Lambin. (2020) Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures. Radiotherapy and Oncology 153, pages 97-105.
Crossref
Geoffrey B Johnson, Hendrik J Harms, Derek R Johnson & Mark S Jacobson. (2020) PET Imaging of Tumor Perfusion: A Potential Cancer Biomarker?. Seminars in Nuclear Medicine 50:6, pages 549-561.
Crossref
Jairo A Socarrás Fernández, David Mönnich, Sara Leibfarth, Stefan Welz, Alex Zwanenburg, Stefan Leger, Steffen Löck, Christina Pfannenberg, Christian La Fougère, Gerald Reischl, Michael Baumann, Daniel Zips & Daniela Thorwarth. (2020) Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy. Physics and Imaging in Radiation Oncology 15, pages 52-59.
Crossref
Marta Bogowicz, Arthur Jochems, Timo M. Deist, Stephanie Tanadini-Lang, Shao Hui Huang, Biu Chan, John N. Waldron, Scott Bratman, Brian O’Sullivan, Oliver Riesterer, Gabriela Studer, Jan Unkelbach, Samir Barakat, Ruud H. Brakenhoff, Irene Nauta, Silvia E. Gazzani, Giuseppina Calareso, Kathrin Scheckenbach, Frank Hoebers, Frederik W. R. Wesseling, Simon Keek, Sebastian Sanduleanu, Ralph T. H. Leijenaar, Marije R. Vergeer, C. René Leemans, Chris H. J. Terhaard, Michiel W. M. van den Brekel, Olga Hamming-Vrieze, Martijn A. van der Heijden, Hesham M. Elhalawani, Clifton D. Fuller, Matthias Guckenberger & Philippe Lambin. (2020) Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer. Scientific Reports 10:1.
Crossref
Anne Laprie, Soléakhéna Ken, Thomas Filleron, Vincent Lubrano, Laure Vieillevigne, Fatima Tensaouti, Isabelle Catalaa, Sergio Boetto, Jonathan Khalifa, Justine Attal, Guillaume Peyraga, Carlos Gomez-Roca, Emmanuelle Uro-Coste, Georges Noel, Gilles Truc, Marie-Pierre Sunyach, Nicolas Magné, Marie Charissoux, Stéphane Supiot, Valérie Bernier, Muriel Mounier, Muriel Poublanc, Amandine Fabre, Jean-Pierre Delord & Elizabeth Cohen-Jonathan Moyal. (2019) Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging. BMC Cancer 19:1.
Crossref
Sven De Bruycker, Christel Vangestel, Tim Van den Wyngaert, Patrick Pauwels, Leonie wyffels, Steven Staelens & Sigrid Stroobants. (2019) 18 F-Flortanidazole Hypoxia PET Holds Promise as a Prognostic and Predictive Imaging Biomarker in a Lung Cancer Xenograft Model Treated with Metformin and Radiotherapy . Journal of Nuclear Medicine 60:1, pages 34-40.
Crossref
Jinrong Zheng, Yuanzhi Shen, Zhiqiang Xu, Zhenwei Yuan, Yuanyuan He, Chen Wei, Murat Er, Jun Yin & Haiyan Chen. (2018) Near-infrared off-on fluorescence probe activated by NTR for in vivo hypoxia imaging. Biosensors and Bioelectronics 119, pages 141-148.
Crossref
David Starostka, Eva Kriegova, Milos Kudelka, Peter Mikula, Sarka Zehnalova, Martin Radvansky, Tomas Papajik, David Kolacek, Katerina Chasakova & Hana Talianova. (2018) Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5‐positive B‐cell neoplasms. Cytometry Part B: Clinical Cytometry 94:4, pages 576-587.
Crossref
Milica Momcilovic & David B. Shackelford. (2018) Imaging Cancer Metabolism. Biomolecules & Therapeutics 26:1, pages 81-92.
Crossref
F.M. Mottaghy. (2017) Non-invasive molecular imaging and theranostic probes. Methods 130, pages 1-3.
Crossref